InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Khan Samina. Director active across 1 company, notably Reata Pharmaceuticals INC. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €332k. Activity tracked since 3 January 2023. The latest transaction was disclosed on 15 May 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Khan Samina is a declarant linked to Reata Pharmaceuticals INC, where the listed function is SVP, Chief Medical Officer. There are 4 filings in total, and across the 4 recent filings available, the activity is mainly sales, with EUR 331893 in sales between 2023-01-04 and 2023-05-17.